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AbstractOpioid free anesthesia (OFA) is gaining popularity as an anesthetic technique to enhance surgical recovery and reduce opioid consumption within the postoperative period. For many decades and continuing today, opioids are administered throughout the perioperative period. Opioid use has dramatically risen and opioid overdose has earned the leading cause of unintentional death in the United States.1 Opioids contain many unfavorable side effects such as potential for abuse or misuse, nausea, vomiting, constipation, ileus, pruritus, altered mental status, urinary retention, respiratory complications, and increased length of hospital stay.1,2 Anesthesia professionals play 
a role in patient’s exposure to opioids, as many patients’ first exposure to opioids may be during the perioperative period.1 An OFA technique was selected for this gender reassignment case to ensure a shorter surgical recovery while avoiding the undesirable side effects of opioids. OFA is a multimodal anesthesia technique including 
hypnotics, NMDA antagonists, local anesthetics, anti-inflammatory drugs, and alpha-2 agonists.4 
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Purpose
• An OFA technique was selected for this gender reassignment 
case report to ensure a shorter surgical recovery while 
avoiding the undesirable side effects of opioids.
Abstract
• Opioid free anesthesia (OFA) is gaining popularity as an 
anesthetic technique to enhance surgical recovery and reduce 
opioid consumption within the postoperative period.
• OFA is a multimodal anesthesia technique including hypnotics, 
NMDA antagonists, local anesthetics, anti-inflammatory drugs, 
and alpha-2 agonists.4
• Opioid use has dramatically risen and opioid overdose has 
earned the leading cause of unintentional death in the United 
States.1
• Opioids contain many unfavorable side effects such as 
potential for abuse or misuse, nausea, vomiting, constipation, 
ileus, pruritus, altered mental status, urinary retention, 
respiratory complications, and increased length of hospital 
stay.1,2
• Anesthesia professionals play a role in patient’s exposure to 
opioids, as many patients’ first exposure to opioids may be 
during the perioperative period.1
• While gender dysphoria (GD) by itself may not trigger 
substance abuse, the stress-related diagnosis can be. 
Discussion
• Koepkel et al found the incidence of chronic opioid use after surgery was 
roughly 6% and this did not differ between major and minor surgical 
procedures in a retrospective study of over 36,000 opioid-naïve patients 
undergoing elective surgery in the USA between 2013 and 2014.2
• OFA technique: Boysen, Pappas, and Evans6 suggest continuous infusions 
of lidocaine and dexmedetomidine with a supplement of low dose volatile 
anesthetic agent and intermittent dosing of acetaminophen, ketamine, 
ibuprofen, and ketorolac.6
• In this case report, 400 mg celecoxib, 400 mg gabapentin, and 975 mg 
acetaminophen were administered preoperatively. 
• Celecoxib selectively inhibits COX-2 to prevent and decrease 
inflammation.7 The recommended dosage of celecoxib is 200 to 400 mg 
one hour prior to surgery.7 Gabapentin binds to voltage-gated calcium 
channels and inhibits the release of excitatory neurotransmitters.5
• Gabapentin is used for chronic neuropathic pain, however, gabapentin has 
been found to reduce acute pain and reduce opioid consumption.5 Graff 
and Grosh stated a normal dose of gabapentin is 300 to 1200 mg three 
times a day.5 However, there has been an analgesic ceiling effect reported 
at 600 mg.7
• Acetaminophen in dosages of 400 and 800 mg were shown to have an 
analgesic and opioid-sparing effect in postoperative patients.6
• Anesthetic maintenance was maintained with magnesium, lidocaine, and 
dexmedetomidine infusions. 
• Magnesium acts as a non-competitive antagonist of the NMDA glutamate 
receptor that prevents depolarization and transmission of pain signals.7
• Magnesium is typically given by a loading dose of 30-50 mg/kg followed 
by a maintenance dose of 6-20 mg/kg/hr until the end of surgery.7
• Lidocaine blocks the sodium channels, however, the mechanism behind 
pain control is yet to be entirely understood.5 Nevertheless, lidocaine is 
capable of producing analgesic, anti-inflammatory, and anti-hyperalgesic 
properties.6 A lidocaine infusion of 0.03 mg/kg/min is recommended 
following induction and for procedures of less than two hours of duration, 
a bolus dose of lidocaine can be considered.6
• Dexmedetomidine is an alpha-2 agonist that contains analgesic, sedative, 
and hypnotic properties.6 Dexmedetomidine is highly selective and specific 
for the alpha receptor and reduces potassium efflux and calcium influx, 
causing hyperpolarization to reduce norepinephrine release.5 Direct alpha-
2 receptor stimulation also impedes nociceptive neuronal firing, making 
dexmedetomidine a useful option for perioperative pain control.5 
Dexmedetomidine is recommended to be infused at 0.5 mcg/kg/hr as an 
intravenous infusion following induction and for procedures of less than 
two hours duration, a bolus dose can be considered.6
• At the end of the case, ketorolac 30 mg was administered. 
• Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits 
prostaglandin synthesis through the COX-1 and COX-2 mechanism of 
action.6 For adult patients, a 15-30 mg intravenous dose of ketorolac has 
been shown to be safe and effective.6
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Case Summary
• A 40-year-old, 63.5 kg, 167.6cm male presented for an orchiectomy, 
penectomy, and vaginoplasty for gender dysmorphia. 
• Past medical history: Attention Deficit Hyperactivity Disorder (ADHD) and 
former smoker for one pack year. Surgical history included a laparoscopic 
cholecystectomy without any anesthesia complications reported. 
• No known drug allergies. The patient’s medications were delestrogen, 
ondansetron, and dextroamphetamine. Laboratory results were 
unremarkable.
• Celecoxib 400 mg, gabapentin 400 mg, acetaminophen 975 mg were 
administered orally, and a scopolamine 1 mg patch was applied topically 
to the patient in the pre-operative holding area. 
• Pre-induction vital signs: pulse 73, blood pressure 109/76 mm Hg, oxygen 
saturation (SpO2) 99%, respirations 16, and temperature 36.6o C. 
• Oxygen was administered with a facemask at 15 L/min for 5 minutes and 
until expired oxygen concentrations were greater than 85%. 
• The patient was induced with lidocaine 60 mg and propofol 200 mg 
intravenously. A laryngeal mask airway (LMA) #4 was applied and 
placement verified with visible chest rise, bilateral breath sounds, and 
sustained end-tidal CO2 with capnography. The patient was able to 
spontaneously breathe throughout the procedure. 
• Decadron 8 mg and cefazolin 1 g were administered intravenously prior to 
the surgical incision. 
• A total of 2 g magnesium, 20 mcg dexmedetomidine, and 50 mg of 
lidocaine were infused intravenously throughout the procedure.
• Anesthesia was initiated with sevoflurane 1.0% end-tidal concentration 
and titrated between 0.5 to 0.8 minimum alveolar concentration (MAC) as 
tolerated in a mixture of medical air 1 L/min and oxygen 1 L/min. 
• Ketorolac 30 mg was administered intravenously at time of surgical wound 
closure. 
• The patient maintained spontaneous respirations between 8-16 breaths
per minute with adequate tidal volumes. The LMA was removed and the 
patient maintained a patent airway. Oxygen was delivered via facemask at 
10 L/min for 5 minutes prior to transferring the patient to the post-
anesthesia care unit (PACU). 
• Vital signs following the procedure were pulse 67, blood pressure 102/65 
mm Hg, respirations 14, SpO2 98%, and temperature 36.4oC. Total PACU 
time was 30 minutes.
• The patient was admitted for overnight observation and evaluation. A 
same day follow-up evaluation revealed stable vital signs, no 
postoperative nausea or vomiting, and a pain score of one. 
• A post-operative day one evaluation revealed the patient received a one-
time dose of fentanyl 25 mcg intravenously in the PACU and one tablet by 
mouth of oxycodone-acetaminophen 5-325 mg over night during 
observation. 
• The patient was discharged with no opioid prescriptions.
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Summary
• Every day in the United States, there are more than 115 people who die from opioid overdose.8
• The Centers for Disease Control and Prevention estimated the economic burden of prescription opioid misuse in the United States to be 
$78.5 billion a year.8
• Anesthesia professionals play an important role in the opioid epidemic by participating in ongoing education on multimodal pain 
management such as implementing OFA techniques.
• Barriers to applying OFA techniques such as the lack of sufficient guidelines, unfamiliarity with the medications used for OFA, resistance 
to change, cost of OFA, and limited data or the need for more evidence-based practice.7
• Benefits of an OFA technique include minimizing respiratory depression, increasing hemodynamic stability intraoperatively, reducing 
postoperative opioid consumption, reducing length of hospital stay, and reducing the risk of opioid-related side effects.7
• OFA technique was selected for this gender reassignment case report in a patient with risk factors for opioid misuse, abuse, and side 
effects due to the possibility of the patient experiencing poor social support, psychological minority stress, vulnerability, and societal 
discrimination.3
• Research emerges daily on OFA techniques and it is the anesthesia professionals’ responsibility to remain current on innovative and 
alternative strategies to provide the safest care to our patients.
Gender Dysphoria
• GD is defined as causing distress due to incongruity between one’s experienced or expressed gender and one’s assigned gender and/or 
primary or secondary sex characteristics.3
• Byne et al discussed the importance of assessing this patient population for suicidal ideation, due to increased risk factors for 
suicidality.3 According to Byne et al, up to 47% of transgender adults have considered or attempted suicide.3
• While GD may not be a trigger for substance abuse alone, the stress-related diagnoses can be a trigger. 
• Minority stress, vulnerability, societal discrimination, identify stigmatization, and issues with access to health care can all contribute to a 
variety of addictive and risky behaviors.3
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